CEO and Chairman of the Board, 10% Owner of Pain Therapeutics (PTIE, Financial) Remi Barbier sells 27,243 shares of PTIE on 07/07/2010 at an average price of $5.35 a share.
Pain Therapeutics has a market cap of $233.1 million; its shares were traded at around $5.47 with and P/S ratio of 11.4.
PTIE is in the portfolios of Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.
Pain Therapeutics has a market cap of $233.1 million; its shares were traded at around $5.47 with and P/S ratio of 11.4.
PTIE is in the portfolios of Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell: CEO and Chairman of Board, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 06/03/2010 at the average price of 5.53. Remi Barbier owns at least 6,121,447 shares after this. The price of the stock has decreased by 1.08% since.
- Sell: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 6,576 shares of PTIE stock on 05/06/2010 at the average price of 5.61. Remi Barbier owns at least 6,171,447 shares after this. The price of the stock has decreased by 2.5% since.
- Sell: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 43,424 shares of PTIE stock on 05/05/2010 at the average price of 5.91. Remi Barbier owns at least 6,178,023 shares after this. The price of the stock has decreased by 7.45% since.
- Sell: CEO and Chairman of Board, 10% Owner Remi Barbier sold 5,800 shares of PTIE stock on 04/07/2010 at the average price of 6.23. Remi Barbier owns at least 6,221,447 shares after this. The price of the stock has decreased by 12.2% since.
- Sell: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 32,200 shares of PTIE stock on 04/06/2010 at the average price of 6.25. Remi Barbier owns at least 6,227,247 shares after this. The price of the stock has decreased by 12.48% since.
Directors and Officers Recent Trades:
- Sell: Chief Scientific Officer Grant Schoenhard sold 1,500 shares of PTIE stock on 06/16/2010 at the average price of 5.45. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 0.37% since.
- Sell: Chief Scientific Officer Grant Schoenhard sold 10,979 shares of PTIE stock on 05/27/2010 at the average price of 5.74. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has decreased by 4.7% since.
- Sell: Chief Scientific Officer Grant Schoenhard sold 2,486 shares of PTIE stock on 05/19/2010 at the average price of 5.77. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has decreased by 5.2% since.
- Sell: Chief Scientific Officer Grant Schoenhard sold 13,035 shares of PTIE stock on 05/18/2010 at the average price of 5.77. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has decreased by 5.2% since.
- Sell: COO Nadav Friedmann sold 15,000 shares of PTIE stock on 05/04/2010 at the average price of 5.95. Nadav Friedmann owns at least 275,951 shares after this. The price of the stock has decreased by 8.07% since.
